Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supp...
Guardado en:
Autores principales: | Peter J. Cook, Rozario Thomas, Ram Kannan, Esther Sanchez de Leon, Alexander Drilon, Marc K. Rosenblum, Maurizio Scaltriti, Robert Benezra, Andrea Ventura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3bc39779c1940f3b63041d39757508e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
por: Peter J. Cook, et al.
Publicado: (2017) -
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor
por: Christopher Alvarez-Breckenridge, et al.
Publicado: (2017) -
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
por: Ana S. Guerreiro Stucklin, et al.
Publicado: (2019) -
Author Correction: Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas
por: Eve Kazarian, et al.
Publicado: (2021) -
A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways
por: Siobhan S. Pattwell, et al.
Publicado: (2020)